Background illustration for clinical trials search

AstraZeneca Clinical Trials

Find clinical trials for AstraZeneca. Search for AstraZeneca clinical trials in different cities and states across the United States.

Filter

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus
Location: West Long Branch NJ, Silver Spring MD, Miami FL,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70

Code: NCT07430306

Phase 3, Recruiting

A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer
Location: Fairfax VA, Atlanta GA, Santa Monica CA
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07098338

Phase 2, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Halifax, Moncton, South Portland ME, Boston MA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase 3, Recruiting

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

for
Clostridioides Difficile Infection
Location: Halifax, Boston MA, Hamden CT, Quebec, Sherbrooke,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07285213

Phase 2, Recruiting

Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

for
Solid Tumours
Location: Providence RI, New York NY, Fairfax VA, Houston TX
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07446855

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

for
Sepsis, Acute Kidney Injury
Location: Boston MA, Levis, Quebec, The Bronx NY, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07215702

Phase 2, Recruiting

AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

for
Large B-cell Lymphoma
Location: Ottawa, Calgary
Sponsor: AstraZeneca

Sex: All

Age: 65 - 70+

Code: NCT07215585

Phase 3, Recruiting

A Study of AZD0120 in Autoimmune Diseases

for
Systemic Sclerosis, Idiopathic Inflammatory Myopathies,
Location: New York NY, Chapel Hill NC, Ann Arbor MI
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07295847

Phase 1, Phase 2, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Moncton, Quebec, The Bronx NY, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

for
Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia,
Location: Durham NC, Decatur IL, Houston TX
Sponsor: AstraZeneca

Sex: All

Age: 16+

Code: NCT07155226

Phase 1, Phase 2, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Halifax, Providence RI, Hartford CT, New Haven CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase 3, Recruiting

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

for
Multiple Sclerosis
Location: New York NY, Washington D.C. DC, Milwaukee WI,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 60

Code: NCT07224373

Phase 1, Recruiting

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

for
B-cell Non-Hodgkin Lymphoma
Location: New York NY, Jacksonville FL, Franklin TN, Rochester MN
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07123454

Phase 1, Phase 2, Recruiting

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

for
Healthy Participants
Location: Baltimore MD, Glendale CA
Sponsor: AstraZeneca

Sex: All

Age: 18 - 55

Code: NCT07290283

Phase 1, Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Burlington MA, Towson MD, Washington D.C. DC,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase 3, Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Toronto, Franklin TN, Chicago IL, Iowa City IA,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT07109219

Phase 1, Phase 2, Recruiting

A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

for
Advanced Solid Tumors
Location: Fairfax VA, Huntersville NC, San Antonio TX
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07161414

Phase 1, Recruiting

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

for
Rheumatoid Arthritis, Systemic Lupus Erythematosus
Location: Mesquite TX, Allen TX, Fullerton CA
Sponsor: AstraZeneca

Sex: All

Age: 18 - 65

Code: NCT07201558

Phase 1, Recruiting

Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Location: Montreal, Margate FL, Miami FL, Springdale AR
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07711002

Phase 3, Recruiting

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

for
Autosomal Dominant Polycystic Kidney Disease
Location: Baltimore MD, Orlando FL, Jacksonville FL, Rochester MN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 65

Code: NCT07228364

Phase 1, Recruiting